{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:17:47Z","timestamp":1791357467900,"version":"4.3.1"},"reference-count":116,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Best Practice &amp; Research Clinical Anaesthesiology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.bpa.2020.08.010","type":"journal-article","created":{"date-parts":[[2020,8,15]],"date-time":"2020-08-15T10:43:19Z","timestamp":1597488199000},"page":"617-631","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Cannabis and cannabidiol (CBD) for the treatment of fibromyalgia"],"prefix":"10.1016","volume":"34","author":[{"given":"Amnon A.","family":"Berger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Winnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elasaf","family":"Gilbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan P.","family":"Eskander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyrus","family":"Yazdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan D.","family":"Kaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Viswanath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Urits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12 SUPPL","key":"10.1016\/j.bpa.2020.08.010_bib1","article-title":"Fibromyalgia: an overview","volume":"122","author":"Clauw","year":"2009","journal-title":"Am J Med"},{"issue":"12 SUPPL","key":"10.1016\/j.bpa.2020.08.010_bib2","article-title":"Diagnosis and differential diagnosis of fibromyalgia","volume":"122","author":"Goldenberg","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/j.bpa.2020.08.010_bib3","first-page":"611","article-title":"AAPT diagnostic criteria for fibromyalgia","volume":"20","author":"Arnold","year":"2019","journal-title":"J\u00a0Pain"},{"issue":"7","key":"10.1016\/j.bpa.2020.08.010_bib4","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/00325481.2017.1336417","article-title":"Challenges of implementing fibromyalgia treatment guidelines in current clinical practice","volume":"129","author":"Arnold","year":"2017","journal-title":"Postgrad Med"},{"issue":"2","key":"10.1016\/j.bpa.2020.08.010_bib5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1136\/annrheumdis-2016-209724","article-title":"EULAR revised recommendations for the management of fibromyalgia","volume":"76","author":"Macfarlane","year":"2017","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.bpa.2020.08.010_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11916-018-0658-8","article-title":"Medical cannabis for neuropathic pain","volume":"22","author":"Lee","year":"2018","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.bpa.2020.08.010_bib7","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/j.mayocp.2018.09.005","article-title":"Medical cannabis","volume":"93","author":"Ebbert","year":"2018","journal-title":"Mayo Clin Proc"},{"issue":"January","key":"10.1016\/j.bpa.2020.08.010_bib8","doi-asserted-by":"crossref","first-page":"116717","DOI":"10.1016\/j.jns.2020.116717","article-title":"Clinical uses of cannabis and cannabinoids in the United States","volume":"411","author":"Levinsohn","year":"2020","journal-title":"J\u00a0Neurol Sci"},{"issue":"15","key":"10.1016\/j.bpa.2020.08.010_bib9","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2014.3266","article-title":"Fibromyalgia: a clinical review","volume":"311","author":"Clauw","year":"2014","journal-title":"JAMA, J Am Med Assoc"},{"issue":"1","key":"10.1016\/j.bpa.2020.08.010_bib10","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1097\/j.pain.0000000000000314","article-title":"A\u00a0systematic review and meta-analysis of the prevalence of chronic widespread pain in the general population","volume":"157","author":"Mansfield","year":"2016","journal-title":"Pain"},{"key":"10.1016\/j.bpa.2020.08.010_bib11","first-page":"252","article-title":"Chronic widespread pain and fibromyalgia syndrome","volume":"46","author":"Shipley","year":"2018","journal-title":"Medicine (United Kingdom)"},{"key":"10.1016\/j.bpa.2020.08.010_bib12","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1136\/bmj.g1224","article-title":"CLINICAL REVIEW fibromyalgia","volume":"348","author":"Rahman","year":"2014","journal-title":"BMJ"},{"issue":"2","key":"10.1016\/j.bpa.2020.08.010_bib13","doi-asserted-by":"crossref","first-page":"e273","DOI":"10.1016\/j.bja.2019.03.023","article-title":"Chronic pain: a review of its epidemiology and associated factors in population-based studies","volume":"123","author":"Mills","year":"2019","journal-title":"Br J Anaesth"},{"issue":"1\u20132","key":"10.1016\/j.bpa.2020.08.010_bib14","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.pain.2008.10.022","article-title":"Premorbid psychosocial factors are associated with poor health-related quality of life in subjects with new onset of chronic widespread pain - results from the EPIFUND study","volume":"141","author":"Nicholl","year":"2009","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.bpa.2020.08.010_bib15","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/papr.12302","article-title":"The comparative burden of chronic widespread pain and fibromyalgia in the United States","volume":"16","author":"Schaefer","year":"2016","journal-title":"Pain Pract"},{"issue":"9","key":"10.1016\/j.bpa.2020.08.010_bib16","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1111\/j.1742-1241.2007.01480.x","article-title":"Characteristics and healthcare costs of patients with fibromyalgia syndrome","volume":"61","author":"Berger","year":"2007","journal-title":"Int J Clin Pract"},{"issue":"9","key":"10.1016\/j.bpa.2020.08.010_bib17","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138024","article-title":"The prevalence and characteristics of fibromyalgia in the 2012 national health interview survey. Cordero MD","volume":"10","author":"Walitt","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.bpa.2020.08.010_bib18","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.berh.2007.03.003","article-title":"Epidemiology of chronic musculoskeletal pain","volume":"21","author":"McBeth","year":"2007","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"5","key":"10.1016\/j.bpa.2020.08.010_bib19","doi-asserted-by":"crossref","first-page":"233","DOI":"10.3109\/03009749309095129","article-title":"Fibromyalgia in the adult Danish population: I. A prevalence study","volume":"22","author":"Prescott","year":"1993","journal-title":"Scand J Rheumatol"},{"issue":"11","key":"10.1016\/j.bpa.2020.08.010_bib20","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1136\/ard.60.11.1040","article-title":"The burden of musculoskeletal diseases in the general population of Spain: results from a national survey","volume":"60","author":"Carmona","year":"2001","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"10.1016\/j.bpa.2020.08.010_bib21","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/art.1780380104","article-title":"The prevalence and characteristics of fibromyalgia in the general population: fibromyalgia prevalence and characteristics","volume":"38","author":"Wolfe","year":"1995","journal-title":"Arthritis Rheum"},{"issue":"5","key":"10.1016\/j.bpa.2020.08.010_bib22","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1002\/acr.21896","article-title":"Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester epidemiology project","volume":"65","author":"Vincent","year":"2013","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.bpa.2020.08.010_bib23","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s00296-017-3725-2","article-title":"Prevalence of fibromyalgia in general population and patients, a systematic review and meta-analysis","volume":"37","author":"Heidari","year":"2017","journal-title":"Rheumatol Int"},{"issue":"3","key":"10.1016\/j.bpa.2020.08.010_bib24","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s00296-017-3840-0","article-title":"Subgrouping fibromyalgia according to prevalence data may lead to a new therapeutic concept","volume":"38","author":"Schirmer","year":"2018","journal-title":"Rheumatol Int"},{"issue":"8","key":"10.1016\/j.bpa.2020.08.010_bib25","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.4088\/JCP.v67n0807","article-title":"Comorbidity of fibromyalgia and psychiatric disorders","volume":"67","author":"Arnold","year":"2006","journal-title":"J\u00a0Clin Psychiatr"},{"issue":"1","key":"10.1016\/j.bpa.2020.08.010_bib26","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0033-3182(99)71272-7","article-title":"Psychiatric disorders in patients with fibromyalgia: A multicenter investigation","volume":"40","author":"Epstein","year":"1999","journal-title":"Psychosomatics"},{"issue":"8","key":"10.1016\/j.bpa.2020.08.010_bib27","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/j.pain.2013.03.034","article-title":"Posttraumatic stress disorder in fibromyalgia syndrome: prevalence, temporal relationship between posttraumatic stress and fibromyalgia symptoms, and impact on clinical outcome","volume":"154","author":"H\u00e4user","year":"2013","journal-title":"Pain"},{"issue":"6","key":"10.1016\/j.bpa.2020.08.010_bib28","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/rheumatology\/keq066","article-title":"A\u00a0cross-sectional survey of 3035 patients with fibromyalgia: subgroups of patients with typical comorbidities and sensory symptom profiles","volume":"49","author":"Rehm","year":"2010","journal-title":"Rheumatology"},{"issue":"9","key":"10.1016\/j.bpa.2020.08.010_bib29","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1007\/s00296-014-2972-8","article-title":"Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity","volume":"34","author":"Haliloglu","year":"2014","journal-title":"Rheumatol Int"},{"issue":"1","key":"10.1016\/j.bpa.2020.08.010_bib30","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.semarthrit.2017.01.005","article-title":"Frequency of concomitant fibromyalgia in rheumatic diseases: monocentric study of 691 patients","volume":"47","author":"Fan","year":"2017","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.bpa.2020.08.010_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.berh.2019.06.005","article-title":"The prevalence and impact of comorbid fibromyalgia in inflammatory arthritis","volume":"33","author":"Zhao","year":"2019","journal-title":"Best Pract Res Clin Rheumatol"},{"issue":"2","key":"10.1016\/j.bpa.2020.08.010_bib32","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3899\/jrheum.090781","article-title":"Chronic conditions and health problems in rheumatic diseases: comparisons with rheumatoid arthritis, noninflammatory rheumatic disorders, systemic lupus erythematosus, and fibromyalgia","volume":"37","author":"Wolfe","year":"2010","journal-title":"J\u00a0Rheumatol"},{"issue":"12 SUPPL","key":"10.1016\/j.bpa.2020.08.010_bib33","article-title":"Pathophysiology of fibromyalgia","volume":"122","author":"Bradley","year":"2009","journal-title":"Am J Med"},{"issue":"5","key":"10.1016\/j.bpa.2020.08.010_bib34","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/art.1780350509","article-title":"Cerebrospinal fluid biogenic amine metabolites in fibromyalgia\/fibrositis syndrome and rheumatoid arthritis","volume":"35","author":"Russell","year":"1992","journal-title":"Arthritis Rheum"},{"issue":"6","key":"10.1016\/j.bpa.2020.08.010_bib35","first-page":"846","article-title":"Towards a model of pathophysiology of fibromyalgia: aberrant central pain mechanisms with peripheral modulation","volume":"19","author":"Yunus","year":"1992","journal-title":"J\u00a0Rheumatol"},{"key":"10.1016\/j.bpa.2020.08.010_bib36","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.neuroscience.2016.06.006","article-title":"Neurobiology of fibromyalgia and chronic widespread pain","volume":"338","author":"Sluka","year":"2016","journal-title":"Neuroscience"},{"issue":"1\u20132","key":"10.1016\/j.bpa.2020.08.010_bib37","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pain.2004.12.032","article-title":"Widespread pain in fibromyalgia is related to a deficit of endogenous pain inhibition","volume":"114","author":"Julien","year":"2005","journal-title":"Pain"},{"issue":"3","key":"10.1016\/j.bpa.2020.08.010_bib38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1097\/00002508-199709000-00003","article-title":"Possible deficiencies of pain modulation in fibromyalgia","volume":"13","author":"Lautenbacher","year":"1997","journal-title":"Clin J Pain"},{"issue":"5","key":"10.1016\/j.bpa.2020.08.010_bib39","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1177\/1073858407312521","article-title":"Fibromyalgia: a disorder of the brain?","volume":"14","author":"Schweinhardt","year":"2008","journal-title":"Neuroscientist"},{"issue":"5","key":"10.1016\/j.bpa.2020.08.010_bib40","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/art.10225","article-title":"Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia","volume":"46","author":"Gracely","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"3","key":"10.1016\/j.bpa.2020.08.010_bib41","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/S0304-3940(98)00937-9","article-title":"Relationship of substance P, 5-hydroxyindole acetic acid and tryptophan in serum of fibromyalgia patients","volume":"259","author":"Schwarz","year":"1999","journal-title":"Neurosci Lett"},{"issue":"10","key":"10.1016\/j.bpa.2020.08.010_bib42","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1002\/art.24849","article-title":"Elevated insular glutamate in fibromyalgia is associated with experimental pain","volume":"60","author":"Harris","year":"2009","journal-title":"Arthritis Rheum"},{"issue":"2","key":"10.1016\/j.bpa.2020.08.010_bib43","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/ijcp.12757","article-title":"Fibromyalgia: management strategies for primary care providers","volume":"70","author":"Arnold","year":"2016","journal-title":"Int J Clin Pract"},{"key":"10.1016\/j.bpa.2020.08.010_bib44","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1001\/jama.292.19.2388","article-title":"Management of fibromyalgia syndrome","volume":"292","author":"Goldenberg","year":"2004","journal-title":"J\u00a0Am Med Assoc"},{"key":"10.1016\/j.bpa.2020.08.010_bib45","doi-asserted-by":"crossref","DOI":"10.1111\/j.1526-4637.2006.00178.x","article-title":"Duloxetine and other antidepressants in the treatment of patients with fibromyalgia","volume":"8","author":"Arnold","year":"2007","journal-title":"Pain Med"},{"issue":"5","key":"10.1016\/j.bpa.2020.08.010_bib46","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.7073cc6c","article-title":"Using multidisciplinary care to treat fibromyalgia","volume":"70","author":"Goldenberg","year":"2009","journal-title":"J\u00a0Clin Psychiatr"},{"issue":"3","key":"10.1016\/j.bpa.2020.08.010_bib47","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0002-9343(01)01089-0","article-title":"A\u00a0randomized, placebo-controlled, double-blind, flexible-dose study of fluoxetine in the treatment of women with fibromyalgia","volume":"112","author":"Arnold","year":"2002","journal-title":"Am J Med"},{"issue":"4","key":"10.1016\/j.bpa.2020.08.010_bib48","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/art.20983","article-title":"Pregabalin for the treatment of Fibromyalgia syndrome: results of a randomized, double-blind, placebo-controlled trial","volume":"52","author":"Crofford","year":"2005","journal-title":"Arthritis Rheum"},{"issue":"4","key":"10.1016\/j.bpa.2020.08.010_bib49","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/art.22457","article-title":"Gabapentin in the treatment of fibromyalgia: a randomized, double-blind, placebo-controlled, multicenter trial","volume":"56","author":"Arnold","year":"2007","journal-title":"Arthritis Rheum"},{"issue":"7","key":"10.1016\/j.bpa.2020.08.010_bib50","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0002-9343(03)00116-5","article-title":"Tramadol and acetaminophen combination tablets in the treatment of fibromyalgia pain: a double-blind, randomized, placebo-controlled study","volume":"114","author":"Bennett","year":"2003","journal-title":"Am J Med"},{"issue":"6","key":"10.1016\/j.bpa.2020.08.010_bib51","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1136\/annrheumdis-2011-200418","article-title":"Sodium oxybate therapy provides multidimensional improvement in fi bromyalgia: results of an international phase 3 trial","volume":"71","author":"Spaeth","year":"2012","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.bpa.2020.08.010_bib52","article-title":"Combination pharmacotherapy for the treatment of fibromyalgia in adults","volume":"2018","author":"Thorpe","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"4","key":"10.1016\/j.bpa.2020.08.010_bib53","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/1529-0131(200008)13:4<198::AID-ANR4>3.0.CO;2-P","article-title":"Sustained improvement produced by nonpharmacologic intervention in fibromyalgia: results of a pilot study","volume":"13","author":"Creamer","year":"2000","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"7","key":"10.1016\/j.bpa.2020.08.010_bib54","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1002\/jcph.1387","article-title":"A\u00a0review of human studies assessing cannabidiol's (CBD) therapeutic actions and potential","volume":"59","author":"White","year":"2019","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"4","key":"10.1016\/j.bpa.2020.08.010_bib55","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1111\/j.1931-0846.2014.12038.x","article-title":"High points: an historical geography of cannabis","volume":"104","author":"Warf","year":"2014","journal-title":"Geogr Rev"},{"issue":"SUPPL. 1","key":"10.1016\/j.bpa.2020.08.010_bib56","article-title":"Cannabinoid pharmacology: the first 66 years","volume":"147","author":"Pertwee","year":"2006","journal-title":"Br J Pharmacol"},{"issue":"8","key":"10.1016\/j.bpa.2020.08.010_bib57","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1021\/ja01062a046","article-title":"Isolation, structure, and partial synthesis of an active constituent of hashish","volume":"86","author":"Gaoni","year":"1964","journal-title":"J\u00a0Am Chem Soc"},{"issue":"5090","key":"10.1016\/j.bpa.2020.08.010_bib58","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1126\/science.1470919","article-title":"Isolation and structure of a brain constituent that binds to the cannabinoid receptor","volume":"258","author":"Devane","year":"1992","journal-title":"Science"},{"issue":"6897","key":"10.1016\/j.bpa.2020.08.010_bib59","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nature00839","article-title":"The endogenous cannabinoid system controls extinction of aversive memories","volume":"418","author":"Marsicano","year":"2002","journal-title":"Nature"},{"issue":"10","key":"10.1016\/j.bpa.2020.08.010_bib60","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1001\/jama.2019.11868","article-title":"Medical use of cannabis in 2019","volume":"322","author":"Hill","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/j.bpa.2020.08.010_bib61","first-page":"989","article-title":"Cannabis as a substitute for prescription drugs - a cross-sectional study","volume":"10","author":"Corroon","year":"2017","journal-title":"J\u00a0Pain Res"},{"key":"10.1016\/j.bpa.2020.08.010_bib62","unstructured":"NCSL (National Conference on State Legislatures. State Medical Marijuana Laws [Internet]. National Conference of State Legislatures. 2020 [cited 2020 Jul 6]. p. 1\u20138. Available from: https:\/\/www.ncsl.org\/research\/health\/state-medical-marijuana-laws.aspx"},{"issue":"24","key":"10.1016\/j.bpa.2020.08.010_bib63","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1001\/jama.2015.6358","article-title":"Cannabinoids for medical use: a systematic review and meta-analysis","volume":"313","author":"Whiting","year":"2015","journal-title":"JAMA - J Am Med Assoc"},{"issue":"10","key":"10.1016\/j.bpa.2020.08.010_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11916-015-0524-x","article-title":"Medical marijuana and chronic pain: a review of basic science and clinical evidence","volume":"19","author":"Jensen","year":"2015","journal-title":"Curr Pain Headache Rep"},{"key":"10.1016\/j.bpa.2020.08.010_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2018.01259","article-title":"Cannabinoids and pain: new insights from old molecules","volume":"9","author":"Vu\u010dkovi\u0107","year":"2018","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bpa.2020.08.010_bib66","article-title":"Medical cannabis for the treatment of chronic Pain\u00a0: a review of clinical effectiveness and guidelines","volume":"vols. 1\u201343","author":"Banerjee","year":"2019"},{"issue":"10","key":"10.1016\/j.bpa.2020.08.010_bib67","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1097\/j.pain.0000000000001293","article-title":"Cannabis and cannabinoids for the treatment of people with chronic non-cancer pain conditions: a systematic review and meta-analysis of controlled and observational studies","volume":"159","author":"Stockings","year":"2018","journal-title":"Pain"},{"key":"10.1016\/j.bpa.2020.08.010_bib68","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1038\/s41394-019-0227-3","article-title":"Using cannabis for pain management after spinal cord injury: a qualitative study","volume":"5","author":"Bourke","year":"2019","journal-title":"Spinal Cord Ser Cases"},{"issue":"1","key":"10.1016\/j.bpa.2020.08.010_bib69","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s00482-015-0084-3","article-title":"Efficacy, tolerability and safety of cannabinoids in chronic pain associated with rheumatic diseases (fibromyalgia syndrome, back pain, osteoarthritis, rheumatoid arthritis): a systematic review of randomized controlled trials","volume":"30","author":"Fitzcharles","year":"2016","journal-title":"Schmerz"},{"issue":"11","key":"10.1016\/j.bpa.2020.08.010_bib70","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1093\/pm\/pny176","article-title":"Restored self: a phenomenological study of pain relief by cannabis","volume":"20","author":"Lavie-Ajayi","year":"2019","journal-title":"Pain Med (United States)"},{"key":"10.1016\/j.bpa.2020.08.010_bib71","first-page":"1","article-title":"Clinical profiles of concurrent cannabis use in chronic pain: a CHOIR study","author":"Sturgeon","year":"2020","journal-title":"Pain Med"},{"issue":"4","key":"10.1016\/j.bpa.2020.08.010_bib72","doi-asserted-by":"crossref","first-page":"301","DOI":"10.9758\/cpn.2017.15.4.301","article-title":"A\u00a0systematic review of the effectiveness of medical cannabis for psychiatric, movement and neurodegenerative disorders","volume":"15","author":"Lim","year":"2017","journal-title":"Clin Psychopharmacol Neurosci"},{"key":"10.1016\/j.bpa.2020.08.010_bib73","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.pnpbp.2015.07.001","article-title":"Therapeutic potential of cannabis-related drugs","volume":"64","author":"Alexander","year":"2016","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatr"},{"issue":"23","key":"10.1016\/j.bpa.2020.08.010_bib74","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMra1402309","article-title":"Adverse health effects of marijuana use","volume":"370","author":"Volkow","year":"2014","journal-title":"New Engl J Med"},{"key":"10.1016\/j.bpa.2020.08.010_bib75","article-title":"Medical cannabis for the primary care physician","volume":"10","author":"Slawek","year":"2019","journal-title":"J\u00a0Prim Care Community Health"},{"issue":"2","key":"10.1016\/j.bpa.2020.08.010_bib76","doi-asserted-by":"crossref","first-page":"56","DOI":"10.64719\/pb.4606","article-title":"Cannabis use and its association with psychological disorders","volume":"50","author":"Urits","year":"2020","journal-title":"Psychopharmacol Bull"},{"issue":"12","key":"10.1016\/j.bpa.2020.08.010_bib77","first-page":"1233","article-title":"Cannabis for the management of pain: assessment of safety study (COMPASS)","volume":"16","author":"Ware","year":"2015","journal-title":"J\u00a0Pain"},{"issue":"6","key":"10.1016\/j.bpa.2020.08.010_bib78","first-page":"1","article-title":"Assessment of efficacy and tolerability of medicinal cannabinoids in patients with multiple sclerosis A systematic review and meta-analysis","volume":"1","author":"Torres-moreno","year":"2018"},{"key":"10.1016\/j.bpa.2020.08.010_bib79","first-page":"139","article-title":"An update on safety and side effects of Cannabidiol\u00a0: a review of clinical data and relevant animal studies","volume":"2","author":"Iffland","year":"2017"},{"issue":"5","key":"10.1016\/j.bpa.2020.08.010_bib80","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2215-0366(19)30048-3","article-title":"The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study","volume":"6","author":"Di Forti","year":"2019","journal-title":"Lancet Psychiat"},{"issue":"3","key":"10.1016\/j.bpa.2020.08.010_bib81","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S2215-0366(14)00117-5","article-title":"Proportion of patients in south London with first-episode psychosis attributable to use of high potency cannabis: a case-control study","volume":"2","author":"Di Forti","year":"2015","journal-title":"Lancet Psychiatr"},{"issue":"1","key":"10.1016\/j.bpa.2020.08.010_bib82","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/0269881112460109","article-title":"Cannabidiol inhibits THC-elicited paranoid symptoms and hippocampal-dependent memory impairment","volume":"27","author":"Englund","year":"2013","journal-title":"J\u00a0Psychopharmacol"},{"issue":"7","key":"10.1016\/j.bpa.2020.08.010_bib83","first-page":"989","article-title":"Potential adverse drug events and drug\u2013drug interactions with medical and consumer cannabidiol (CBD) use","volume":"8","author":"Brown","year":"2019","journal-title":"J\u00a0Clin Med"},{"key":"10.1016\/j.bpa.2020.08.010_bib84","first-page":"1394","article-title":"Are side effects of cannabidiol (CBD) products caused by tetrahydrocannabinol (THC) contamination? F1000Research","volume":"8","author":"Lachenmeier","year":"2020"},{"issue":"5","key":"10.1016\/j.bpa.2020.08.010_bib85","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S1474-4422(03)00381-8","article-title":"The therapeutic potential of cannabis","volume":"2","author":"Baker","year":"2003","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.bpa.2020.08.010_bib86","doi-asserted-by":"crossref","first-page":"107495","DOI":"10.1016\/j.pharmthera.2020.107495","article-title":"Cannabinoids in the descending pain modulatory circuit: role in inflammation","volume":"209","author":"Bouchet","year":"2020","journal-title":"Pharmacol Ther"},{"issue":"8","key":"10.1016\/j.bpa.2020.08.010_bib87","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1038\/s41584-018-0025-5","article-title":"Cannabinoids for the treatment of rheumatic diseases - where do we stand?","volume":"14","author":"Katz-Talmor","year":"2018","journal-title":"Nat Rev Rheumatol"},{"issue":"1","key":"10.1016\/j.bpa.2020.08.010_bib88","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s40122-019-0114-4","article-title":"An update of current cannabis-based pharmaceuticals in pain medicine","volume":"8","author":"Urits","year":"2019","journal-title":"Pain Ther"},{"issue":"3","key":"10.1016\/j.bpa.2020.08.010_bib89","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/0091-3057(91)90385-F","article-title":"Recent clinical experience with dronabinol","volume":"40","author":"Plasse","year":"1991","journal-title":"Pharmacol Biochem Behav"},{"issue":"February","key":"10.1016\/j.bpa.2020.08.010_bib90","first-page":"1","article-title":"Cannabidiol drugs clinical trial outcomes and adverse effects","volume":"11","author":"Pauli","year":"2020","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.bpa.2020.08.010_bib91","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/j.mayocp.2019.01.003","article-title":"Clinicians' guide to cannabidiol and hemp oils","volume":"94","author":"VanDolah","year":"2019","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"10.1016\/j.bpa.2020.08.010_bib92","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1002\/cbdv.200790152","article-title":"Human cannabinoid pharmacokinetics","volume":"4","author":"Huestis","year":"2007","journal-title":"Chem Biodiversity"},{"issue":"1","key":"10.1016\/j.bpa.2020.08.010_bib93","doi-asserted-by":"crossref","DOI":"10.5041\/RMMJ.10389","article-title":"Cannabis and cannabinoids in the treatment of rheumatic diseases","volume":"11","author":"Gonen","year":"2020","journal-title":"Rambam Maimonides Med J"},{"issue":"12","key":"10.1016\/j.bpa.2020.08.010_bib94","doi-asserted-by":"crossref","first-page":"102409","DOI":"10.1016\/j.autrev.2019.102409","article-title":"Cannabinoids in the treatment of rheumatic diseases: pros and cons","volume":"18","author":"Sarzi-Puttini","year":"2019","journal-title":"Autoimmun Rev"},{"issue":"8","key":"10.1016\/j.bpa.2020.08.010_bib95","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1002\/acr.21732","article-title":"Association of herbal cannabis use with negative psychosocial parameters in patients with fibromyalgia","volume":"64","author":"Ste-Marie","year":"2012","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"5","key":"10.1016\/j.bpa.2020.08.010_bib96","doi-asserted-by":"crossref","first-page":"257","DOI":"10.5055\/jom.2009.0028","article-title":"Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State","volume":"5","author":"Aggarwal","year":"2009","journal-title":"J\u00a0Opioid Manag"},{"issue":"4","key":"10.1016\/j.bpa.2020.08.010_bib97","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018440","article-title":"Cannabis use in patients with fibromyalgia: effect on symptoms relief and health-related quality of life. Garc\u00eda AV","volume":"6","author":"Fiz","year":"2011","journal-title":"PloS One"},{"issue":"10","key":"10.1016\/j.bpa.2020.08.010_bib98","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1111\/add.14719","article-title":"Persistence of use of prescribed cannabinoid medicines in Manitoba, Canada: a population-based cohort study","volume":"114","author":"Alkabbani","year":"2019","journal-title":"Addiction"},{"issue":"4","key":"10.1016\/j.bpa.2020.08.010_bib99","first-page":"18","article-title":"Cannabinoids in health and disease","volume":"9","author":"Kogan","year":"2007","journal-title":"Clin Res"},{"issue":"5","key":"10.1016\/j.bpa.2020.08.010_bib100","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1111\/j.1365-2125.2011.03970.x","article-title":"Cannabinoids for treatment of chronic non-cancer pain; a systematic review of randomized trials","volume":"72","author":"Lynch","year":"2011","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.bpa.2020.08.010_bib101","first-page":"CD012182","article-title":"Cannabis-based medicines for chronic neuropathic pain in adults","volume":"3","author":"M\u00fccke","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"10.1016\/j.bpa.2020.08.010_bib102","first-page":"CD011694","article-title":"Cannabinoids for fibromyalgia","volume":"18","author":"Brian","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"10.1016\/j.bpa.2020.08.010_bib103","first-page":"164","article-title":"Nabilone for the treatment of pain in fibromyalgia","volume":"9","author":"Skrabek","year":"2008","journal-title":"J\u00a0Pain"},{"issue":"2","key":"10.1016\/j.bpa.2020.08.010_bib104","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1213\/ANE.0b013e3181c76f70","article-title":"The effects of nabilone on sleep in fibromyalgia: results of a randomized controlled trial","volume":"110","author":"Ware","year":"2010","journal-title":"Anesth Analg"},{"issue":"5","key":"10.1016\/j.bpa.2020.08.010_bib105","first-page":"343","article-title":"Characteristics of medical cannabis usage among patients with fibromyalgia","volume":"159","author":"Habib","year":"2020","journal-title":"Harefuah"},{"issue":"Suppl 1","key":"10.1016\/j.bpa.2020.08.010_bib106","first-page":"53","article-title":"Adding medical cannabis to standard analgesic treatment for fibromyalgia: a prospective observational study","volume":"38","author":"Giorgi","year":"2020","journal-title":"Clin Exp Rheumatol"},{"issue":"7","key":"10.1016\/j.bpa.2020.08.010_bib107","first-page":"449","article-title":"The powers of flowers: evaluating the impact of floral therapy on pain and psychiatric symptoms in fibromyalgia","volume":"21","author":"Yavne","year":"2019","journal-title":"Isr Med Assoc J IMAJ"},{"key":"10.1016\/j.bpa.2020.08.010_bib108","first-page":"7829427","article-title":"The consumption of cannabis by fibromyalgia patients in Israel","volume":"2018","author":"Habib","year":"2018","journal-title":"Pain Res Treat"},{"issue":"5","key":"10.1016\/j.bpa.2020.08.010_bib109","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/RHU.0000000000000702","article-title":"Medical cannabis for the treatment of fibromyalgia","volume":"24","author":"Habib","year":"2018","journal-title":"J\u00a0Clin Rheumatol Pract Rep Rheum Musculoskelet Dis"},{"issue":"6","key":"10.1016\/j.bpa.2020.08.010_bib110","first-page":"807","article-title":"Safety and efficacy of medical cannabis in fibromyalgia","volume":"8","author":"Sagy","year":"2019","journal-title":"J\u00a0Clin Med"},{"issue":"4","key":"10.1016\/j.bpa.2020.08.010_bib111","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1097\/j.pain.0000000000001464","article-title":"An experimental randomized study on the analgesic effects of pharmaceutical-grade cannabis in chronic pain patients with fibromyalgia","volume":"160","author":"Van De Donk","year":"2019","journal-title":"Pain"},{"issue":"16","key":"10.1016\/j.bpa.2020.08.010_bib112","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMclde1808149","article-title":"Medical marijuana for chronic pain","volume":"379","author":"Caulley","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"16","key":"10.1016\/j.bpa.2020.08.010_bib113","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMclde1808149","article-title":"Medical marijuana for chronic pain A woman with chronic pain discourage the use of medical marijuana","volume":"379","author":"Caulley","year":"2018","journal-title":"N\u00a0Engl J Med"},{"issue":"10","key":"10.1016\/j.bpa.2020.08.010_bib114","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1097\/j.pain.0000000000001293","article-title":"Cannabis and cannabinoids for the treatment of people with chronic non-cancer pain conditions: a systematic review and meta-analysis of controlled and observational studies","volume":"159","author":"Stockings","year":"2018","journal-title":"Pain"},{"issue":"5","key":"10.1016\/j.bpa.2020.08.010_bib115","doi-asserted-by":"crossref","first-page":"532","DOI":"10.3899\/jrheum.181120","article-title":"Position statement: a pragmatic approach for medical cannabis and patients with rheumatic diseases","volume":"46","author":"Fitzcharles","year":"2019","journal-title":"J\u00a0Rheumatol"},{"issue":"24","key":"10.1016\/j.bpa.2020.08.010_bib116","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1001\/jama.2015.6199","article-title":"Medical marijuana for treatment of chronic pain and other medical and psychiatric problems: a clinical review","volume":"313","author":"Hill","year":"2015","journal-title":"JAMA, J Am Med Assoc"}],"container-title":["Best Practice &amp; Research Clinical Anaesthesiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689620300781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1521689620300781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T11:30:04Z","timestamp":1776425404000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1521689620300781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":116,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1521689620300781"],"URL":"https:\/\/doi.org\/10.1016\/j.bpa.2020.08.010","relation":{},"ISSN":["1753-3740"],"issn-type":[{"value":"1753-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cannabis and cannabidiol (CBD) for the treatment of fibromyalgia","name":"articletitle","label":"Article Title"},{"value":"Best Practice & Research Clinical Anaesthesiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bpa.2020.08.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}